Slide background

Slide background
Slide background
Slide background

Loading Events
December
2019
3
New York Cancer Genomics Research Network Meeting

5:00 PM — 8:00 PM

Moderated by Harold Varmus, MD

See New York Genome Center’s lecture series, events and archives VIEW FULL CALENDAR

About

To advance collaborative efforts on cancer genomics, the New York Genome Center (NYGC) hosts meetings on the first Tuesday of every month to bring together leading cancer researchers, clinicians and postdocs from the NYGC’s Institutional Founding Members and other key academic institutions. The organizers include Drs. Harold Varmus (NYGC & Weill Cornell Medicine), Marcin Imielinski (NYGC &Weill Cornell Medicine), Ross Levine (Memorial Sloan Kettering Cancer Center) and Sohail Tavazoie (The Rockefeller University). 

WHEN:
Tuesday, December 3, 2019
5:00 PM – 7:00 PM: Speaker Presentations and Q&A
7:00 PM – 8:00 PM: Hors d’oeuvres & Networking

WHERE:
New York Genome Center
101 Avenue of the Americas, 1st Floor Auditorium

REGISTER

 

MODERATOR
Harold Varmus, MD 
Senior Associate Core Member
New York Genome Center

Lewis Thomas University Professor of Medicine
Weill Cornell Medicine

 

 

 

 

SPEAKERS


Aristotelis Tsirigos, PhD
Associate Professor, Department of Pathology
NYU School of Medicine

 

 

To learn more about Dr. Tsirigos‘ research, visit his lab page.

 

 

 


David A. Knowles, PhD
Core Faculty Member
New York Genome Center

Assistant Professor, Department of Computer Science
Assistant Professor, Department of Systems Biology
Columbia University

 

 

 

To learn more about Dr. Knowles’ research, visit his lab page.

 

 

 


Matthew Greenblatt, MD, PhD

Assistant Professor of Pathology and Laboratory Medicine
Weill Cornell Medicine

 

 

To learn more about Dr. Greenblatt’s research, visit his lab page.

 

 

 

 

 

Discussion and Q&A
Moderated by Harold Varmus, MD
Discussion and Q&A will take place after each speaker presents.
These meetings are held on the first Tuesday of each month and are intended for principal investigators in the New York region and their trainees.
Any questions on this event, contact events@nygenome.org.

 

 

  • EVENING TALKS
    The New York Genome Center’s Evening Talks events feature distinguished experts from around the world sharing genomic insights and research. They are intended to showcase and explain high science to the non-scientific community. Speakers present the latest research findings and explain its implication for helping improve clinical care for a wide array of serious diseases. The lecture is followed by a lively question-and-answer session and a post-event reception of hors d’oeuvres and cocktails. These popular free public events are held in the Center’s state-of-the-art ground-floor auditorium starting at 6:30 pm. The Evening Talks Series is sponsored by The New York Community Trust – Pyewacket Fund.

  • Workshops
  • Computational Cancer Genomics Working Group Evening Lectures
    Computational Cancer Genomics Working Group is led by Simon Tavaré, PhD, NYGC and Columbia University, and Sohrab Shah, PhD, Memorial Sloan Kettering Cancer Center. This group will build collaborations that apply novel statistical approaches and population-level analyses to major cohorts in cancer genomics.

  • Neurodegenerative Disease Working Group Evening Lectures
    The NYGC is leveraging the success of the Center for Genomics of Neurodegenerative Disease (CGND) to extend our work across a range of neurodegenerative diseases that have pathways in common with ALS, including Alzheimer’s, Parkinson’s and Huntington’s diseases. The NYGC has created a new Neurodegenerative Disease Working Group, led by Alison Goate, DPhil, Icahn School of Medicine at Mount Sinai, Hemali Phatnani, PhD, NYGC, and Phil De Jager, PhD, MD, MMSc, Columbia University Irving Medical Center, with the objective of bringing together researchers from NYGC’s institutional founding members, NYGC faculty, senior faculty, NYGC technology development and computational scientists, and affiliate members to discuss the underlying disease mechanisms in neurodegenerative disease.